FairScope Lab
EN 繁中 简中

BMY

Valuation Healthcare · Drug Manufacturers - General Data as of 2026-03-31

P/E Ratio · Metrics

P/E Ratio

11.57

PEG Ratio

0.17

Dividend Yield

-

Gross Margin

70.22%

Net Margin

23.31%

Revenue CAGR 3Y

0.44%

ROE

53.38%

ROA

12.39%

Buyback Yield

-0.12%

Current Ratio

1.42

Magic Earn Yield

8.24%

Altman Z-Score

1.79

Fair Value River

Score

Valuation 75
Profitability 67
Growth 1
Health 42
Yield 0
← Back to Dashboard